Title : Rosuvastatin: a high-potency HMG-CoA reductase inhibitor.

Pub. Date : 2005 Jul-Aug

PMID : 16128507






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DATA SYNTHESIS: Multiple clinical trials have revealed that use of rosuvastatin is associated with greater reductions in low-density lipoprotein cholesterol (LDL-C) across the dose range of 5-40 mg/day than any other currently available statins. Rosuvastatin Calcium component of oligomeric golgi complex 2 Homo sapiens
2 Rosuvastatin may allow more patients to achieve their LDL-C goals than any other statin and at a lower dose than other agents. Rosuvastatin Calcium component of oligomeric golgi complex 2 Homo sapiens